A Phase 2 Study of Paclitaxel With Cisplatin Versus Fluoropyrimidine With a Platinum Agent for Neoadjuvant Therapy in Operable Esophageal Cancer Based on CHFR Methylation Status in Diagnostic Biopsies
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Cisplatin; Fluoropyrimidine derivatives; Paclitaxel; Platinum complexes
- Indications Gastric cancer; Oesophageal cancer
- Focus Therapeutic Use
Most Recent Events
- 25 Jan 2019 Biomarkers information updated
- 15 Jun 2011 New trial record